HOME >> MEDICINE >> NEWS
Toward the future of cancer prevention

ial.

Other chemopreventive agents have proven to be effective. M. D. Anderson researchers have found that:

  • A low-dose baby aspirin proved effective as a modest colon cancer chemopreventive. A randomized clinical trial of more than 1,000 participants found it reduced the number of precancerous polyps by 19 percent. Robert Bresalier, M.D., chair of the Department of Gastrointestinal Medicine and Nutrition, helped lead this national effort.
  • Celecoxib, a non-steroidal anti-inflammatory drug (NSAID) known by the trade name Celebrex, reduced the number of colon polyps in people who have familial adenomatous polyposis (FAP), in which hundreds of precancerous polyps form in the colon and rectum. The study, led by researchers at M. D. Anderson and St. Mark's Hospital, London, in collaboration with the National Cancer Institute, led to federal approval of Celebrex for FAP patients.
  • Supplements of selenium and vitamin E unexpectedly reduced the incidence of prostate cancer by up to two-thirds in trials testing them for different cancers. These observations led to the ongoing international Selenium and Vitamin E Cancer Prevention Trial (SELECT) in more than 32,000 patients. M. D. Anderson leaders of SELECT include Lippman and Elise D. Cook, M.D., who led the national effort to recruit minority men, especially African-Americans, who have the highest risk of prostate cancer in the world. Cook's successful campaign resulted in the highest percentage of African-Americans ever recruited to a large-scale cancer prevention trial.
  • The spice curcumin (found in turmeric and curry powders) has shown dramatic results in preventing cancer in animal studies, and has led to clinical studies at M. D. Anderson with patients that have pancreatic cancer or multiple myeloma. A trial with breast cancer patients is expected to begin in 2005. Patients in these trials take curcumin capsules daily.

A number of ongoing chemoprevention tria
'"/>

Contact: Nancy Jensen
nwjensen@mdanderson.org
713-794-1584
University of Texas M. D. Anderson Cancer Center
16-Dec-2005


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. NIH scientists target future pandemic strains of H5N1 avian influenza
2. The Eli and Edythe Broad Foundation invests in gastroenterologys future
3. The future of biofuels is not in corn
4. The future of biofuels is not in corn
5. Inactive kids storing up illness for the future
6. SCAIs Therapies in Evolution showcases exciting future of interventional cardiology
7. Conception date affects babys future academic achievement
8. ASU, Walter Reed researchers create prosthesis of the future
9. Why GNEP cant jump to the future
10. NeuroArm: Navigating the future of surgery
11. IceSAR campaign provides glimpse of future Sentinel-1 images over ice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Toward the future cancer prevention

(Date:7/6/2015)... ... 06, 2015 , ... University of Pittsburgh Cancer Institute (UPCI) scientists ... to reflect newly available tests that better incorporate personalized medicine into diagnosing the condition. ... cancer tests is published in the July issue of the scientific journal Thyroid ...
(Date:7/6/2015)... Branford, Connecticut (PRWEB) , ... July 06, 2015 ... ... Aesthetic Medical Practice & Medical Spa industries, announces the return of its complimentary ... the Acara team of aesthetic medical business leaders creates success for their clients ...
(Date:7/6/2015)... BC (PRWEB) , ... July 06, 2015 , ... Olive ... received the UBC 2014-2015 Post Graduate Teaching Award on behalf of the department of ... is a very exciting field to be practicing in. The technology is changing so ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... newly-diagnosed cancer patients, caregivers and medical professionals to chat with the CHN patient ... cancer. , “Receiving a cancer diagnosis is often the most traumatic experience of ...
(Date:7/6/2015)... ... , ... MD Now, the leading and fastest-growing urgent care provider in Florida, ... will serve residents and visitors in the Cutler Bay area, giving them convenient access ... location, the new facility will be the fourth to serve Miami-Dade County. Located at ...
Breaking Medicine News(10 mins):Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3
(Date:7/6/2015)... , July 6, 2015 Moerae Matrix, ... novel therapeutics that target inflammation and fibrosis, today ... M.D., PhD, as Chief Medical Officer. ... development strategy and programs, which include a pipeline ... and fibrotic conditions.  Bill is an accomplished strategist ...
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., a ... including those with rare and orphan inflammatory disease indications, ... U.S. Food and Drug Administration (FDA) to begin a ... acebilustat (CTX-4430), in adult CF patients in the US. ... Europe will be filed soon after. ...
(Date:7/6/2015)... SUNNYVALE, Calif. , July 6, 2015   ... will report financial results for its 2015 second quarter ... after the close of the market. The ... Pacific Time on Thursday, July 23, 2015, to discuss ... Cepheid,s website at http://ir.cepheid.com at least 15 ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
Cached News: